Elekta AB (publ) (EKTAY)

Market Cap	2.27B
Revenue (ttm)	1.85B
Net Income (ttm)	30.75M
Shares Out	n/a
EPS (ttm)	0.08
PE Ratio	73.77
Forward PE	15.11
Dividend	0.14 (2.38%)
Ex-Dividend Date	Sep 8, 2025

Volume	300
Average Volume	12,010
Open	6.01
Previous Close	5.87
Day's Range	6.01 - 6.01
52-Week Range	4.35 - 6.29
Beta	1.06
RSI	72.04
Earnings Date	Nov 26, 2025

About Elekta AB

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as wel...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1972
• Employees: 4,556
• Stock Exchange: OTCMKTS
• Ticker Symbol: EKTAY

Financial Performance

In 2025, Elekta AB's revenue was 18.02 billion, a decrease of -0.57% compared to the previous year's 18.12 billion. Earnings were 237.00 million, a decrease of -81.80%.

Financial numbers in SEK